fluorobenzenes has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, CA; Fleming, JW; Malinowski, SS; Miller, KH; Riche, DM; Wofford, MR | 1 |
Athyros, VG; Giouleme, O; Karagiannis, A; Kargiotis, K; Katsiki, E; Katsiki, N; Mikhailidis, DP; Patsiaoura, K | 1 |
Barabanchyk, OV; Kozak, NP; Svintsits'kyÄ, AS | 1 |
Dubrovins'ka, TV; Skrypnyk, IM | 1 |
Aguila, MB; Fraulob, JC; Mandarim-de-Lacerda, CA; Souza-Mello, V | 1 |
Itoh, Y; Jo, M; Kagawa, K; Kimura, H; Minami, M; Mitsumoto, Y; Mitsuyoshi, H; Nakajima, T; Nishikawa, T; Nishimura, T; Okada, Y; Okanoue, T; Tochiki, N; Yamaguchi, K; Yasui, K | 1 |
2 trial(s) available for fluorobenzenes and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report.
Topics: Adult; Biopsy; Drug Administration Schedule; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Liver Function Tests; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2014 |
[Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
Topics: Atorvastatin; Bilirubin; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipids; Liver; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Transaminases; Triglycerides; Ursodeoxycholic Acid | 2014 |
5 other study(ies) available for fluorobenzenes and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Dyslipidemias; Fatty Liver; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones | 2014 |
[CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA].
Topics: Adult; Allopurinol; Bile; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Cholesterol; Cholic Acid; Deoxycholic Acid; Drug Therapy, Combination; Duodenoscopy; Female; Fluorobenzenes; Humans; Hyperuricemia; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Taurocholic Acid; Uric Acid; Ursodeoxycholic Acid | 2014 |
[Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis].
Topics: Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2014 |
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
Topics: Adipokines; Adipose Tissue; Adiposity; Animals; Blood Glucose; Body Composition; Diet, High-Fat; Fatty Liver; Fluorobenzenes; Homeostasis; Insulin Resistance; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Pyrimidines; Resistin; Rosiglitazone; Rosuvastatin Calcium; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Thiazolidinediones; Triglycerides | 2012 |
Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Acyl-CoA Oxidase; Alanine Transaminase; Animals; Azo Compounds; Carnitine O-Palmitoyltransferase; Catalase; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; DNA Primers; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Nonesterified; Fatty Liver; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Liver; Male; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2013 |